Fig. 2From: Cerebrospinal fluid penetration of meropenem in neurocritical care patients with proven or suspected ventriculitis: a prospective observational studyComparison of different dosing regimens as prolonged infusions over 4 h using the pharmacokinetics model. Median time course of meropenem concentrations simulated in serum and cerebrospinal fluid (CSF) over 4 days. Targeted meropenem trough concentrations in CSF were 1 mg/L, 2 mg/L and 4 mg/LBack to article page